Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2019
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Ronan J Kelly, Jeeyun Lee, Yung-Jue Bang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer: Retrospective Global Experience
Steven B Maron, Stephanie Moya, Federica Morano, et al.
JAMA Network Open
|
February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial
Daniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
JAMA Oncology
|
September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial
Andrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2019
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Jason Willis, Martina I Lefterova, Alexander Artyomenko, et al.
The Lancet. Oncology
|
July 13, 2020
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial
Daniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, et al.
Cell Reports
|
July 28, 2021
A pan-cancer organoid platform for precision medicine
Brian M Larsen, Madhavi Kannan, Lee F Langer, et al.
Nature Medicine
|
August 15, 2022
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
Christine D Palmer, Amy R Rappaport, Matthew J Davis, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2019
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Ronan J Kelly, Jeeyun Lee, Yung-Jue Bang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer: Retrospective Global Experience
Steven B Maron, Stephanie Moya, Federica Morano, et al.
JAMA Network Open
|
February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial
Daniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
JAMA Oncology
|
September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial
Andrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2019
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Jason Willis, Martina I Lefterova, Alexander Artyomenko, et al.
The Lancet. Oncology
|
July 13, 2020
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial
Daniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, et al.
Cell Reports
|
July 28, 2021
A pan-cancer organoid platform for precision medicine
Brian M Larsen, Madhavi Kannan, Lee F Langer, et al.
Nature Medicine
|
August 15, 2022
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
Christine D Palmer, Amy R Rappaport, Matthew J Davis, et al.
Page
of 7